Aurobindo Pharma Limited

NSE: AUROPHARMA

Compare with…

Employs 29,209 permanent employees and workers, 5.4% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹2,917 cr.

Headcount

Annual, from the BRSR filed with NSE (as of 31 March each year)

Permanent
Contract / other
As ofScopePermanentChange (%)Contract / otherChange (%)
31 Mar 2023Group23,451—9,962—
31 Mar 2024Group26,0152,564(10.9%)11,5811,619(16.3%)
31 Mar 2025Group27,7071,692(6.5%)13,0431,462(12.6%)
31 Mar 2026Group29,2091,502(5.4%)17,2464,203(32.2%)

Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.

Financials (₹ cr)

Revenue (₹ cr)
Employee cost (₹ cr)
Net profit (₹ cr)
PeriodRevenue (₹ cr)Change (%)Employee cost (₹ cr)Change (%)Net profit (₹ cr)Change (%)Flags
Quarter ended 31 Dec 20242,91792(3.3%)265−0(0.1%)472−66(12.2%)
Quarter ended 30 Sept 20242,825365(14.8%)2666(2.4%)538209(63.4%)
Quarter ended 30 Jun 20242,460−434(15.0%)25910(4.2%)329−250(43.1%)
Quarter ended 31 Mar 20242,894202(7.5%)2491(0.3%)579−45(7.2%)
Quarter ended 31 Dec 20232,69223(0.9%)2481(0.2%)624208(50.1%)
Quarter ended 30 Sept 20232,669278(11.6%)24811(4.8%)41680(23.7%)
Quarter ended 30 Jun 20232,391−1,157(32.6%)236−171(42.0%)336−309(47.9%)
Quarter ended 31 Mar 20233,547115(3.4%)407−12(2.8%)645346(115.8%)
Quarter ended 31 Dec 20223,432545(18.9%)41832(8.3%)299−503(62.7%)
Quarter ended 31 Mar 20222,887264(10.1%)386−7(1.8%)802562(234.5%)⚠
Quarter ended 31 Dec 20212,623−260(9.0%)3944(1.1%)24042(21.3%)⚠
Quarter ended 30 Sept 20212,883−11(0.4%)389−41(9.6%)198−17(8.1%)⚠
Quarter ended 30 Jun 20212,894−1,220(29.7%)431−14(3.1%)215−658(75.3%)⚠
Quarter ended 31 Mar 20214,114403(10.9%)44514(3.2%)873132(17.8%)⚠
Quarter ended 31 Dec 20203,711−813(18.0%)4314(1.1%)741−61(7.6%)⚠
Quarter ended 30 Sept 20204,5241,105(32.3%)4272(0.4%)80287(12.2%)⚠
Quarter ended 30 Jun 20203,420−201(5.5%)425−0(0.1%)715−10(1.4%)⚠
Quarter ended 31 Mar 20203,620275(8.2%)42540(10.4%)725306(73.0%)⚠
Quarter ended 31 Dec 20193,346124(3.9%)38511(2.9%)41921(5.3%)⚠
Quarter ended 30 Sept 20193,222−26(0.8%)37424(6.9%)398−65(14.1%)⚠
Quarter ended 31 Dec 20183,24878(2.5%)35018(5.4%)46483(21.7%)⚠
Quarter ended 30 Sept 20183,170816(34.6%)33214(4.5%)38173(23.6%)⚠
Quarter ended 31 Mar 20182,355—317—308—⚠